title: [Phospholipid and cholesterol levels in the tumor cell plasma membranes with different sensitivity to doxorubicin].
abstract: The investigation is aimed to study qualitative and quantitative composition of phospholipids, cholesterol content and lipids unsaturation index in plasma membranes of Guerin's carcinoma cells sensitive or resistant to doxorubicin. The comparison of infrared spectra and phospholipids unsaturation index showed that the unsaturation level of fatty acids in plasma membrane from resistant cells was lower than that from sensitive carcinoma cells. 31P-NMR spectroscopy of plasma membranes phospholipids shows the increase of phosphatidylserine and sphingomyeline content in plasma membrane isolated from resistant tumor as compared with sensitive tumor. The levels of phosphatidylcholine and phosphatidylethanolamine were equal in drug-resistant and drug-sensitive carcinoma strains. Changes in plasma membrane from resistant cells result in elevation of plasma membrane microviscosity and phosphatidylserine level increase can suggest the activation of P-glycoprotein-mediated efflux of doxorubicin.
authors.affiliation: Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Science of Ukraine, Kyiv.
authors.forename: V F
authors.initials: VF
authors.lastname: Chekhun
authors.forename: V P
authors.initials: VP
authors.lastname: Tryndiak
authors.forename: I M
authors.initials: IM
authors.lastname: Todor
authors.forename: V M
authors.initials: VM
authors.lastname: Mykhaĭlenko
authors.forename: I H
authors.initials: IH
authors.lastname: Kondrychyn
authors.forename: H I
authors.initials: HI
authors.lastname: Dovbeshko
authors.forename: O P
authors.initials: OP
authors.lastname: Repnyts'ka
authors.forename: H I
authors.initials: HI
authors.lastname: Kulyk
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology* / Q000627:therapeutic use; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism*; D002784:Cholesterol / Q000378:metabolism; D004317:Doxorubicin / Q000494:pharmacology* / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm; D008297:Male; D008560:Membrane Fluidity / Q000187:drug effects*; D008563:Membrane Lipids / Q000378:metabolism*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D014407:Tumor Cells, Cultured
chemical_list: D000903:Antibiotics, Antineoplastic; D008563:Membrane Lipids; D010743:Phospholipids; D004317:Doxorubicin; D002784:Cholesterol